XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses:        
Research and development $ 5,960 $ 8,420 $ 10,023 $ 8,646
General and administrative 1,649 242 3,098 437
Total operating expenses 7,609 8,662 13,121 9,083
Loss from operations (7,609) (8,662) (13,121) (9,083)
Other income (expense), net:        
Change in fair value of anti-dilution right liability   (11)   (11)
Other income, net 381   531  
Total other income (expense), net 381 (11) 531 (11)
Net loss and comprehensive loss (7,228) (8,673) (12,590) (9,094)
Accretion of redeemable convertible preferred stock to redemption value   (70)   (70)
Net loss attributable to common stockholders $ (7,228) $ (8,743) $ (12,590) $ (9,164)
Net loss per share attributable to common stockholders - basic and diluted $ (2.21) $ (94.86) $ (7.29) $ (137.97)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted 3,268,390 92,171 1,726,795 66,422